Gut microbiome in type 1 diabetes: the immunological perspective

References

• Wang Z, Xie Z, Lu Q, et al. Beyond genetics: what causes type 1 diabetes. Clin Rev Allerg Immunol. 2016;52920:273–584.
   Google Scholar
• International Diabetes Federation, IDF diabetes atlas, 10th edition 2021. https://diabetesatlas.org
   Google Scholar
• Fenneman AC, Rampanelli E, Yin YS, et al. Gut microbiota and metabolites in the pathogenesis of endocrine disease. Biochem Soc TArans. 2020;48:915–931.
   PubMed Web of Science ®Google Scholar
• Roep BO, Tree TI. Immune modulation in humans: implications for type 1 diabetes mellitus. Nat Rev Endocrinol. 2014;10:229–242.
   PubMed Web of Science ®Google Scholar
• Hummel M, Bonifacio E, Schmid S, et al. Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic patients. Ann Intern Med. 2004;140:882–886.
   PubMed Web of Science ®Google Scholar
• Achenbach P, Bonifacio E, Koczwara K, et al. Natural history of type 1 diabetes. Diabetes. 2005;54(suppl.2):S25–31.
   PubMedGoogle Scholar
• Kaufman DL, Erland MG, Clare-Salzler M, et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. JClin Invest. 1992;89:283–292.
   PubMed Web of Science ®Google Scholar
• Yoon JW, Onodera T, Notkins AL. Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J Exp Med. 1978;148:1068–1080.
   PubMed Web of Science ®Google Scholar
• Luopajarvi K, Savilahti E, Virtanen SM, et al. Enhanced levels of cow’s milk antibodies in infancy in children who develop type 1 diabetes later in childhood. Pediatr Diabetes. 2008;9:434‐41.
   PubMed Web of Science ®Google Scholar
• Du T, Zhou Z, You S, et al. Regulation by 1, 25‐dihydroxy‐vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin Chim Acta. 2009;402(1–2):133‐8.
   Web of Science ®Google Scholar
• Ghazarian L, Diana J, Simoni Y, et al. Prevention or acceleration of type 1 diabetes by viruses. Cell Mol Life Sci. 2013;70(2):239‐55.
   PubMed Web of Science ®Google Scholar
• Li X, Atkinson MA. The role for gut permeability in the pathogenesis of type 1 diabetes—a solid or leaky concept? Pediatr Diabetes. 2015;16(7):485‐92.
   Web of Science ®Google Scholar
• Wernroth ML, Fall K, Svennblad B, et al. Early childhood antibiotic treatment for otitis media and other respiratory tract infections is associated with risk of type 1 diabetes: a nationwide register-based study with sibling analysis. Diabetes Care. 2020;43(5):991–999.
   PubMed Web of Science ®Google Scholar
• James EA, Pietropaolo M, Mamula MJ. Immune recognition of β-cells: neoepitopes as key players in the loss of tolerance. Diabetes. 2018;67(6):1035–1042.
   PubMed Web of Science ®Google Scholar
• Pugliese A. Autoreactive T cells in type 1 diabetes. J Clin Invest. 2017;127(8):2881–2891.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Calvo T, Krogvold L, Amirian N, et al. One in Ten CD8+ cells in the pancreas of living individuals with recent-onset type 1 diabetes recognizes the preproinsulin epitope PPI15-24. Diabetes. 2021;70:752–758.
   PubMed Web of Science ®Google Scholar
• Burrack AL, MartinovA T, Fife BT. T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes. Front Endocrinol. 2017;8:343.
   PubMed Web of Science ®Google Scholar
• Krischer JP, Lynch KF, Schatz DA, et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia. 2015;58(5):980–987.
   PubMed Web of Science ®Google Scholar
• Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA. 2007;104(43):17040–17045.
   PubMed Web of Science ®Google Scholar
• Jacobsen LM, Bocchino L, Evans-Molina C, et al. The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening. Diabetologia. 2020;63(3):588–596.
   PubMed Web of Science ®Google Scholar
• Vehik K, Bonifacio E, Lernmark Å, et al. Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY study. Diabetes Care. 2020;43(9):2066–2073.
   PubMed Web of Science ®Google Scholar
• Orban T, Sosenko JM, Cuthbertson D, et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care. 2009;32(12):2269–2274.
   PubMed Web of Science ®Google Scholar
• Akashi T, Nagafuchi S, Anzai K, et al. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol. 1997;9(8):1159–1164.
   PubMed Web of Science ®Google Scholar
• Fiorina P, Vergani A, Dada S, et al. Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes. 2008;57(11):3013–3024.
   PubMed Web of Science ®Google Scholar
• Wong FS, Wen L, Tang M, et al. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes. 2004;53(10):2581–2587.
   PubMed Web of Science ®Google Scholar
• Smith MJ, Cambier JC, Gottlieb PA. Endotypes in T1D: b lymphocytes and early onset. Curr Opin Endocrinol Diabetes Obes. 2020;27(4):225–230.
   PubMedGoogle Scholar
• Gearty SV, Dündar F, Zumbo P, et al. An autoimmune stem-like CD8 T cell population drives type 1 diabetes. Nature. 2022;602(7895):156–161.
   PubMed Web of Science ®Google Scholar
• ElTanbouly MA, Noelle RJ. Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey. Nat Rev Immunol. 2021;21(4):257–267.
   PubMed Web of Science ®Google Scholar
• Edner NM, Carlesso G, Rush JS, et al. Targeting co-stimulatory molecules in autoimmune disease. Nat Rev Drug Discov. 2020;19(12):860–883.
   PubMed Web of Science ®Google Scholar
• Orban T, Bundy B, Becker DJ, et al. Costimulation modulation with Abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment. Diabetes Care. 2014;37:1069–1075.
   PubMed Web of Science ®Google Scholar
• Edner NM, Heuts F, Thomas N, et al. Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes. Nat Immunol. 2020;21:1244–1255.
   PubMed Web of Science ®Google Scholar
• Boldison J, Da Rosa LC, Davies J, et al. Dendritic cells license regulatory B cells to produce IL-10 and mediate suppression of antigen-specific CD8 T cells. Cell Mol Immunol. 2020;17:843–855.
   PubMed Web of Science ®Google Scholar
• Hull CM, Peakman M, Tree TIM. Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it? Diabetologia. 2017;60:1839–1850.
   PubMed Web of Science ®Google Scholar
• Raffin C, Vo LT, Bluestone JA. Treg cell-based therapies: challenges and perspectives. Nat Rev Immunol. 2020;20:158–172.
   PubMed Web of Science ®Google Scholar
• Lindley S, Dayan CM, Bishop A, et al. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes. 2005;54:92–99.
   PubMed Web of Science ®Google Scholar
• Long SA, Cerosaletti K, Bollyky PL, et al. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes. 2010;59:407–415.
   PubMed Web of Science ®Google Scholar
• Ellis JS, Wan X, Braley-Mullen H. Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice. Immunology. 2013;139:179–186.
   PubMed Web of Science ®Google Scholar
• Tang Q, Henriksen KJ, Bi M, et al. In Vitro–expanded antigen-specific regulatory t cells suppress autoimmune diabetes. J Exp Med. 2004;199:1455–1465.
   PubMed Web of Science ®Google Scholar
• Marek-trzonkowskaan N, Myśliwiec M, Dobyszuk A, et al. Therapy of type 1 diabetes with CD4+CD25highCD127-regulatory T cells prolongs survival of pancreatic islets — results of one year follow-up. Clinic Immunol. 2014;153:23–30.
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Buckner JH, Fitch M, et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci Transl Med. 2015;7:15ra189.
   Web of Science ®Google Scholar
• Wiedeman AE, Muir VS, Rosasco MG, et al. Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression. J Clin Invest. 2020;130:480–490.
   PubMed Web of Science ®Google Scholar
• Diggins KE, Serti E, Muir V, et al. Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects. JCI Insight. 2021;6:e142680.
   PubMed Web of Science ®Google Scholar
• Roep BO, Thomaidou S, van Tienhoven R, et al. Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system? Nat Rev Endoc. 2021;17:150–161.
   PubMed Web of Science ®Google Scholar
• Damond N, Engler S, Zanotelli VRT, et al. A map of human type 1 diabetes progression by imaging mass cytometry. Cell Metab. 2019;29:755–768.
   PubMed Web of Science ®Google Scholar
• Foulis AK, Jackson R, Farquharson MA. The pancreas in idiopathic Addison’s disease–a search for a prediabetic pancreas. Histopathology. 1988;12:481–490.
   PubMed Web of Science ®Google Scholar
• Coppieters KT, Dotta F, Amirian N, et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med. 2012;209:51–60.
   PubMed Web of Science ®Google Scholar
• Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115–1118.
   PubMed Web of Science ®Google Scholar
• Donaldson GP, Lee M, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microb. 2016;14:20–32.
   PubMed Web of Science ®Google Scholar
• Sender R, Fuchs S, Milo R. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell. 2016;164:337–340.
   PubMed Web of Science ®Google Scholar
• Gensollen T, Iyer SS, Kasper DL, et al. How colonization by microbiota in early life shapes the immune system. Science. 2016;352:539–544.
   PubMed Web of Science ®Google Scholar
• Round JL, Mazmanian SK. The gut microbiome shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2000;9:313–323.
   Google Scholar
• Hapfelmeier S, Lawson MA, Slack E, et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science. 2010;328:1705–1709.
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, LiuC H, Tzianabos AO, et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122(1):107e18.
   Web of Science ®Google Scholar
• Gordon HA. Morphological and physiological characterization of germfree life. Ann N Y Acad Sci. 1959;78:208e20.
   Web of Science ®Google Scholar
• Chung H, Pamp SJ, Hill JA, et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell. 2012;149:1578e93.
   Web of Science ®Google Scholar
• Khosravi A, Yanez A, Price JG, et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe. 2014;15:374e81.
   Web of Science ®Google Scholar
• Cash HL, Whitham CV, Behrendt CL, et al. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 2006;313:1126e30.
   Web of Science ®Google Scholar
• Pickard JM, Zeng MY, Caruso R, et al. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 2017;279:70–89.
   PubMed Web of Science ®Google Scholar
• Thoo L, Noti M, Krebs P. Keep calm: the intestinal barrier at the interface of peace and war. Cell Death Dis. 2019;10:849.
   PubMed Web of Science ®Google Scholar
• Johansson MEV, Jakobsson HE, Holmén-Larsson J, et al. Normalization of host intestinal mucus layers requires long-term microbial colonization. Cell Host Microbe. 2015;18:582–592.
   PubMed Web of Science ®Google Scholar
• Wang Y, Telesford KM, Ochoa-Repáraz J, et al. Intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat Commun. 2014;5:4432.
   PubMed Web of Science ®Google Scholar
• Telesford KM, Yan W, Ochoa-Reparaz J, et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and treg function. Gut Microbes. 2015;6:234–242.
   PubMed Web of Science ®Google Scholar
• Brown EM, Kenny DJ, Xavier RJ. Gut microbiota regulation of T cells during inflammation and autoimmunity. Annu Rev Immunol. 2019;37:599–624.
   PubMed Web of Science ®Google Scholar
• Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500:232–236.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485–498.
   PubMed Web of Science ®Google Scholar
• Chervonsky AV. Microbiota and autoimmunity. Cold Spring Harb Perspect Biol. 2013;5:a007294.
   PubMed Web of Science ®Google Scholar
• Skelly AN, Sato Y, Kearney S, et al. Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol. 2019;19:305–323.
   PubMed Web of Science ®Google Scholar
• den Besten G, van Eunen K, Groen AK, et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54:2325–2340.
   PubMed Web of Science ®Google Scholar
• Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16:341–352.
   PubMed Web of Science ®Google Scholar
• Quivy V, Van Lint C. Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation. Biochem Pharmacol. 2004;68:1221–1229.
   PubMed Web of Science ®Google Scholar
• Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282–1286.
   PubMed Web of Science ®Google Scholar
• Vinolo MA, Rodrigues HG, Hatanaka E, et al. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. 2011;22:849e55.
   Web of Science ®Google Scholar
• Millard AL, Mertes PM, Ittelet D, et al. Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin Exp Immunol. 2002;130:245e55.
   Web of Science ®Google Scholar
• Chang PV, Hao L, Offermanns S, et al. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014;111:2247e52.
   Web of Science ®Google Scholar
• Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451–455.
   PubMed Web of Science ®Google Scholar
• Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504:446–450.
   PubMed Web of Science ®Google Scholar
• Garabatos N, Santamaria P. Gut microbial antigenic mimicry in autoimmunity. Front Immunol. 2022;13:873607.
   PubMed Web of Science ®Google Scholar
• Tai N, Peng J, Liu F, et al. Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice. J Exp Med. 2016;213:2129–2146.
   PubMed Web of Science ®Google Scholar
• Girdhar K, Huang Q, Chow I, et al. A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes. Proc Natl Acad Sci U S A. 2022;119:e2120028119.
   PubMedGoogle Scholar
• Nanjundappa RH, Ronchi F, Wang J, et al. A gut microbial mimic that hijacks diabetogenic autoreactivity to suppress colitis. Cell. 2017;171:655–667.
   PubMed Web of Science ®Google Scholar
• de Goffau MC, Luopajarvi K, Knip M, et al. Fecal microbiota composition differs between children with beta‐cell autoimmunity and those without. Diabetes. 2013;62:1238‐44.
   PubMed Web of Science ®Google Scholar
• Davis‐Richardson AG, Ardissone AN, Dias R, et al. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front Microbiol. 2014;5:678.
   PubMed Web of Science ®Google Scholar
• de Goffau MC, Fuentes S, van den Bogert B, et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia. 2014;57:1569‐77.
   PubMed Web of Science ®Google Scholar
• Brown CT, Davis‐Richardson AG, Giongo A, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One. 2011;6:e25792.
   PubMed Web of Science ®Google Scholar
• Maffeis C, Martina A, Corradi M, et al. Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes. Diabetes Metab Res Rev. 2016;32:700‐9.
   PubMed Web of Science ®Google Scholar
• Murri M, Leiva I, Gomez-Zumaquero JM, et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013;11:46.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Gevers D, Siljander H, et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 2015;17:260–273.
   PubMed Web of Science ®Google Scholar
• Qi C, Zhang Q, Yu M, et al. Imbalance of fecal microbiota at newly diagnosed type 1 diabetes in Chinese children. Chin Med J. 2016;129:1298–1304.
   PubMed Web of Science ®Google Scholar
• Giongo A, Gano KA, Crabb DB, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011;5:82–91.
   PubMed Web of Science ®Google Scholar
• Vatanen T, Franzosa EA, Schwager R, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018;562:589–594.
   PubMed Web of Science ®Google Scholar
• de Groot PF, Belzer C, Ö A, et al. Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study. PLoS One. 2017;12:e0188475.
   PubMed Web of Science ®Google Scholar
• van Heck JIP, Gacesa R, Stienstra R, et al. The Gut microbiome composition is altered in long-standing type 1 diabetes and associates with glycemic control and disease-related complications. Diabetes Care. 2022;45:2084–2094.
   PubMed Web of Science ®Google Scholar
• Mosterd CM, Kanbay M, van den Born BJH, et al. Intestinal microbiota and diabetic kidney diseases: the role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression. Best Pract Res Clin Endocrinol Metab. 2021;35:101484.
   PubMed Web of Science ®Google Scholar
• Stewart CJ, Ajami NJ, O’Brien JL, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562:583–588.
   PubMed Web of Science ®Google Scholar
• Alkanani AK, Hara N, Gottlieb PA, et al. Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes. 2015;64:3510–3520.
   PubMed Web of Science ®Google Scholar
• Wen L, Ley RE, Volchkov PY, et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature. 2008;455:1109–1113.
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Signore A, Williams AJK, et al. NOD mouse colonies around the world - recent facts and figures. Immunol Today. 1993;14:193–196.
   PubMedGoogle Scholar
• Burrows MP, Volchkov P, Kobayashi KS, et al. Microbiota regulates type 1 diabetes through Toll-like receptors. Proc Natl Acad Sci USA. 2016;112:9973–9977.
   Web of Science ®Google Scholar
• Gülden E, Ihira M, Ohashi A, et al. Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice. PLoS ONE. 2013;8(9):e75385.
   PubMed Web of Science ®Google Scholar
• Hänninen A, Toivonen R, Sakari P, et al. Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut. 2018;67(8):1373–1374.
   PubMed Web of Science ®Google Scholar
• Endesfelder D, Engel M, Davis-Richardson AG, et al. Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production. Microbiome. 2016;4(1):17.
   PubMedGoogle Scholar
• Martin AK, Sefik E, Hill JA, et al. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci USA. 2011;108(28):11548–11553.
   PubMed Web of Science ®Google Scholar
• O’Connor W Jr, Kamanaka M, Booth CJ, et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009;10(6):603–609.
   PubMed Web of Science ®Google Scholar
• Roesch LFW, Lorca GL, Casella G, et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. SME J. 2009;3:536–548.
   Google Scholar
• Lai KK, Lorca GL, Gonzalez CF. Biochemical properties of two cinnamoyl esterases purified from a lactobacillus johnsonii strain isolated from stool samples of diabetes-resistant rats. Appl Environ Microbiol. 2009;75:5018–24.
   PubMed Web of Science ®Google Scholar
• Valladares R, Sankar D, Li N, et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP Rats. PLoS One. 2010;5(5):e10507.
   PubMed Web of Science ®Google Scholar
• Diana J, Gahzarian L, Simoni Y, et al. Innate immunity in type 1 diabetes. Discov Med. 2011;11(61):513–520.
   PubMed Web of Science ®Google Scholar
• Pearson JA, Wong FS, Wena L. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. J Autoimmun. 2016;66:76–88.
   PubMed Web of Science ®Google Scholar
• Lee KU, Amano K, Yoon JW. Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes. 1988;37(7):989–991.
   PubMed Web of Science ®Google Scholar
• Nikolic T, Geutskens SB, van Rooijen N, et al. Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study. Lab Invest. 2005;85(4):487–501.
   PubMed Web of Science ®Google Scholar
• Sofi MH, Gudi R, Karumuthil-Melethil S, et al. pH of drinking water influences the composition of gut microbiome and type 1 diabetes incidence. Diabetes. 2014;63(2):632–644.
   PubMed Web of Science ®Google Scholar
• Tchitchek N, Tchoumba ON, Pires G, et al. Low-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation. JCI Insight. 2022;7(17):e159406.
   PubMed Web of Science ®Google Scholar
• Bosi E, Molteni L, Radaelli MG, et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia. 2006;49(12):2824–2827.
   PubMed Web of Science ®Google Scholar
• Leiva-Gea I, Sánchez-Alcoholado L, Martín-Tejedor B, et al. Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case-control study. Diabetes Care. 2018;41(11):2385–2395.
   PubMed Web of Science ®Google Scholar
• Sapone A, de Magistris L, Pietzak M, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006;55(5):1443–1449.
   PubMed Web of Science ®Google Scholar
• Sorini C, Cosorich I, Lo Conte M, et al. Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes. Proc Natl Acad Sci USA. 2019;116(30):15140–15149.
   PubMed Web of Science ®Google Scholar
• Pöysti S, Toivonen R, Takeda A, et al. Infection with the enteric pathogen C. rodentium promotes islet-specific autoimmunity by activating a lymphatic route from the gut to pancreatic lymph node. Mucosal Immunol. 2022;15(3):471–479.
   PubMed Web of Science ®Google Scholar
• Costa FRC, Françozo MCS, de Oliveira GG, et al. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. J Exp Med. 2016;213(7):1223–1239.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Pan Y, Zeng B, et al. Intestinal lysozyme liberates Nod1 ligands from microbes to direct insulin trafficking in pancreatic beta cells. Cell Res. 2019;29(7):516–532.
   PubMed Web of Science ®Google Scholar
• Mariño E, Richards JL, McLeod KL, et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol. 2017;18(5):552–562.
   PubMed Web of Science ®Google Scholar
• Jacob N, Jaiswal S, Maheshwari D, et al. Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes. Sci Rep. 2020;10(1):19120.
   PubMed Web of Science ®Google Scholar
• Jia L, Cao M, Chen H, et al. Butyrate ameliorates antibiotic-driven type 1 diabetes in the female offspring of nonobese diabetic mice. J Agric Food Chem. 2020;68(10):3112–3120.
   PubMed Web of Science ®Google Scholar
• Guo Y, Xiao Z, Wang Y, et al. Sodium butyrate ameliorates streptozotocin-induced type 1 diabetes in mice by inhibiting the HMGB1 expression. Front Endocrinol. 2018;9:630.
   PubMed Web of Science ®Google Scholar
• Okada M, Zhang V, Loaiza Naranjo JD, et al. Islet-specific CD8+ T cells gain effector function in the gut lymphoid tissues via bystander activation not molecular mimicry. Immunol Cell Biol. 2022. DOI:10.1111/imcb.12593.
   PubMed Web of Science ®Google Scholar
• Renz H, Adkins BD, Bartfeld S, et al. The neonatal window of opportunity—early priming for life. J Allergy Clin Immunol. 2018;141(4):1212–1214.
   PubMed Web of Science ®Google Scholar
• van den Elsen LWJ, Garssen J, Burcelin R, et al. Shaping the gut microbiota by breastfeeding: the gateway to allergy prevention? Front Pediatr. 2019;7:47.
   PubMed Web of Science ®Google Scholar
• Nielsen DS, Krych L, Buschard K, et al. Beyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes. FEBS Lett. 2014;e588(22):4234–4243.
   Google Scholar
• Knip M, Virtanen SV, Akerblom HK, et al. Infant feeding and the risk of type 1 diabetes. Am J Clin Nutr. 2010;91(5):1506S–13S.
   PubMed Web of Science ®Google Scholar
• Hummel S, Ziegler AG. Early determinants of type 1 diabetes: experience from the BABYDIAB and BABYDIET studies. Am J Clinic Nutrition. 2011;84(suppl_6):1821S–3S.
   Google Scholar
• Marietta EV, Gomez AM, Yeoman C, et al. Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS One. 2013;8(11):e78687.
   PubMed Web of Science ®Google Scholar
• Borch-Johnsen K, Joner G, Mandrup-Poulsen T, et al. Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis. Lancet. 1984;2(8411):1083–1086.
   PubMed Web of Science ®Google Scholar
• Lund-Blix NA, Sander SD, Størdal K, et al. Infant feeding and risk of type 1 diabetes in two large Scandinavian birth cohorts. Diabetes Care. 2017;40(7):920–927.
   PubMed Web of Science ®Google Scholar
• Cardwell CR, Stene LC, Ludvigsson J, et al. Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care. 2012;35(11):2215–2225.
   PubMed Web of Science ®Google Scholar
• l X, Van’t Land B, Engen PA, et al. Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice. Sci Rep. 2018;8(1):3829.
   PubMedGoogle Scholar
• Silverman M, Kua L, Tanca A, et al. Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny. Proc Natl Acad Sci USA. 2017;114:9671–9676.
   PubMed Web of Science ®Google Scholar
• Mullaney JA, Stephens JE, Geeling BE, et al. Early-life exposure to gut microbiota from disease-protected mice does not impact disease outcome in type 1 diabetes susceptible NOD mice. Imunol Cell Biol. 2019;97(1):97–103.
   PubMed Web of Science ®Google Scholar
• Neuman V, Cinek O, Funda DP, et al. Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor. Diabetologia. 2019;62(7):1291–1296.
   PubMed Web of Science ®Google Scholar
• Ruiz VE, Kurtz, ZD, Battaglia T, et al. A single early-in-life macrolide course has lasting effects on murine microbial network topology and immunity. Nat Comm. 2017;8(1):518.
   PubMedGoogle Scholar
• Livanos AE, Greiner TU, Vangay P, et al. Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nat Microbiol. 2016;1(11):16140.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li J, Krautkramer KA, et al. Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity. eLife. 2018;7:e37816.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yin YS, Wang J, et al. Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice. Cell Host Microbe. 2021;19:1259–1265.
   Google Scholar
• Hansen CHF, Krych L, Nielsen DS, et al. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia. 2012;55(8):2285–2294.
   PubMed Web of Science ®Google Scholar
• Hu Y, Peng J, Tai N, et al. Maternal antibiotic treatment protects offspring from diabetes development in nonobese diabetic mice by generation of tolerogenic APCs. J Immunol. 2015;195(9):4176–4184.
   PubMed Web of Science ®Google Scholar
• Tilg H, Adolph TE. Beyond digestion: the pancreas shapes intestinal microbiota and immunity. Cell Metab. 2017;25(3):495–496.
   PubMed Web of Science ®Google Scholar
• Ahuja M, Schwartz DM, Tandon M, et al. Orai1-mediated antimicrobial secretion from pancreatic acini shapes the gut microbiome and regulates gut innate immunity. Cell Metab. 2017;25(3):635–646.
   PubMed Web of Science ®Google Scholar
• Sun J, Furio L, Mecheri R, et al. Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity. 2015;43(2):304–317.
   PubMed Web of Science ®Google Scholar
• Pound LD, Patrick C, Eberhard CE, et al. Cathelicidin antimicrobial peptide: a novel regulator of islet function, islet regeneration, and selected gut bacteria. Diabetes. 2015;64(12):4135–4147.
   PubMed Web of Science ®Google Scholar
• Liang W, Enée E, Andre-Vallee C. Intestinal cathelicidin antimicrobial peptide shapes a protective neonatal gut microbiota against pancreatic autoimmunity. Gastroenterology. 2022;162(4):1288–302.e16.
   PubMed Web of Science ®Google Scholar
• Pahar B, Madonna S, Das A, et al. Immunomodulatory role of the antimicrobial LL-37 peptide in autoimmune diseases and viral infections. Vaccines (Basel). 2020;8(3):517.
   PubMed Web of Science ®Google Scholar
• Bell KJ, Saad S, Tillett BJ, et al. Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation. Microbiome. 2022;10(1):9.
   PubMed Web of Science ®Google Scholar
• Mariño E, Batten M, Groom J, et al. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes. 2008;57(2):395–404.
   PubMed Web of Science ®Google Scholar
• de Groot PF, Nikolic T, Imangaliyev S, et al. Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial. Diabetologia. 2020;63(3):597–610.
   PubMed Web of Science ®Google Scholar
• de Groot P, Nikolic T, Pellegrini S, et al. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Gut. 2021;70(1):92–105.
   PubMed Web of Science ®Google Scholar
• Burke SJ, Karlstad MD, Eder AE, et al. Pancreatic β-cell production of CXCR3 ligands precedes diabetes onset. Biofactors. 2016;42(6):703–715.
   PubMed Web of Science ®Google Scholar
• Frigerio S, Junt T, Lu B, et al. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med. 2002;8(12):1414–1420.
   PubMed Web of Science ®Google Scholar
• Roep BO, Kleijwegt FS, van Halteren AGS, et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol. 2010;159(3):338–343.
   PubMed Web of Science ®Google Scholar
• Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroent Hepat. 2017;14(8):491–502.
   PubMed Web of Science ®Google Scholar
• Kellow NJ, Coughlan MT, Reid CM, et al. Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. Br J Nutr. 2014;111(7):1147–1161.
   PubMed Web of Science ®Google Scholar
• Dehghan P, Gargari BP, Jafar-Abadi MA, et al. Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized-controlled clinical trial. Int J Food Sci Nutr. 2014;65(1):117–123.
   PubMed Web of Science ®Google Scholar
• Ho J, Nicolucci AC, Virtanen H, et al. Effect of prebiotic on microbiota, intestinal permeability, and glycemic control in children with type 1 diabetes. J Clinc Endoc Metab. 2019;104(10):4427–4440.
   PubMed Web of Science ®Google Scholar
• Marcial GE, Ford AL, Haller MJ, et al. Lactobacillus johnsonii N6.2 modulates the host immune responses: a double-blind, randomized trial in healthy adults. Front Immunol. 2017;8:655.
   PubMed Web of Science ®Google Scholar
• Gambardella J, Castellanos V, Santulli G. Standardizing translational microbiome studies and metagenomic analyses. Cardiovasc Res. 2021;117(3):640–642.
   PubMed Web of Science ®Google Scholar
• Allaband C, Lingaraju A, Ramos SF, et al. Time of sample collection critical for microbiome replicability. BioRxiv. 2022.
   Google Scholar
• Galloway-Peña J, Hanson B. Tools for analysis of the microbiome. Dig Dis Sci. 2021;65(3):674–685.
   Web of Science ®Google Scholar
• Korpela K, Helve O, Kolho K, et al. Maternal fecal microbiota transplantation in cesarean-born infants rapidly restores normal gut microbial development: a proof-of-concept study. Cell. 2020;183(2):324–34.e5.
   PubMed Web of Science ®Google Scholar